Omega Pharma NV
Omega Pharma NV, a leading player in the pharmaceutical and healthcare industry, is headquartered in Belgium (BE) and operates extensively across Europe. Founded in 1987, the company has established itself as a key provider of over-the-counter (OTC) products, dietary supplements, and personal care solutions, focusing on enhancing consumer health and well-being. With a diverse portfolio that includes well-known brands in pain relief, cold and flu remedies, and skincare, Omega Pharma distinguishes itself through its commitment to quality and innovation. The company has achieved significant milestones, including strategic acquisitions that have bolstered its market position. Recognised for its dedication to research and development, Omega Pharma continues to thrive in a competitive landscape, making a notable impact on the health and wellness sector.
DitchCarbon Score
How does Omega Pharma NV's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Omega Pharma NV's score of 46 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Omega Pharma NV, headquartered in Belgium (BE), currently does not report specific carbon emissions data, as no figures are available. The company is a current subsidiary of Perrigo Company plc, which may influence its climate commitments and reporting practices. While Omega Pharma NV has not established its own reduction targets or climate pledges, it is important to note that emissions data and sustainability initiatives may be cascaded from Perrigo Company plc. This relationship suggests that Omega Pharma NV could align with the broader sustainability goals set by its parent company, although specific details on these initiatives are not provided. As the industry increasingly prioritises climate action, Omega Pharma NV's future commitments and strategies may evolve to reflect the growing emphasis on reducing carbon footprints and enhancing environmental sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Omega Pharma NV is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
